Owaves Nearly Doubles Enrollment Target in First Prospective Randomized Clinical Trial with UC San Diego

Owaves Nearly Doubles Enrollment Target in First Prospective Randomized Clinical Trial with UC San Diego

Summary

/PRNewswire-PRWeb/ -- Owaves, Inc., creator of BodyClock AI™, the world's first AI platform for circadian health, today announced the close of enrollment for....

Description

/PRNewswire-PRWeb/ -- Owaves, Inc., creator of BodyClock AI™, the world's first AI platform for circadian health, today announced the close of enrollment for....

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source